Analysis of an innovative fluid biomarker panel for early prediction of progression independent of relapse activity in multiple sclerosis
{{output}}
Background: Progression independent of relapse activity (PIRA) may occur in patients with relapsing multiple sclerosis (MS) and is a major contributor to disability accumulation. ... ...
